This topic contains a solution. Click here to go to the answer

Author Question: A model that uses a system of symbols to represent a problem is called a. mathematical. b. iconic. ... (Read 115 times)

jeatrice

  • Hero Member
  • *****
  • Posts: 543
A model that uses a system of symbols to represent a problem is called
 a. mathematical.
  b. iconic.
  c. analog.
  d. constrained.

Question 2

The miles per gallon obtained by the 1995 model Q cars is normally distributed with a mean of 22 miles per gallon and a standard deviation of 5 miles per gallon.
 a. What is the probability that a car will get between 13.35 and 35.1 miles per gallon?
  b. What is the probability that a car will get more than 29.6 miles per gallon?
  c. What is the probability that a car will get less than 21 miles per gallon?
  d. What is the probability that a car will get exactly 22 miles per gallon?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Bison

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

A

Answer to Question 2

a. .9538
b. .0643
c. .4207
d. 0




jeatrice

  • Member
  • Posts: 543
Reply 2 on: Jun 24, 2018
YES! Correct, THANKS for helping me on my review


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library